Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 CNS 3 Thoracic 2 Gynecologic 2 Genitourinary 2 Tumor-Agnostic 1 Sarcoma 1 Other neoplasm 1 Head & Neck 1 Gastrointestinal 1 Endocrine 1

Conditions

Thyroid Cancer, Papillary 1 Lymphatic Metastasis 1

Interventions

Cisplatin 630 Radiotherapy 339 pembrolizumab 329 Cetuximab 283 Docetaxel 225 Radiotherapy, Intensity-Modulated 221 Fluorouracil 199 Carboplatin 198 Paclitaxel 161 Nivolumab 145 Gemcitabine 125 Magnetic Resonance Spectroscopy 99 Radiation 91 Drug Therapy 86 Capecitabine 76 toripalimab 74 Surveys and Questionnaires 73 Surgical Procedures, Operative 72 Biopsy 62 durvalumab 61 Chemoradiotherapy 52 Blood Specimen Collection 52 Cyclophosphamide 48 Specimen Handling 47 camrelizumab 46 Radiosurgery 46 Erlotinib Hydrochloride 46 Standard of Care 43 130-nm albumin-bound paclitaxel 43 tislelizumab 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Spectrum Analysis × Head & Neck × Clear all

NCT03470259 2024-04-16

TARGET

University Medical Center Groningen

Phase 1 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡